Phillips Wealth Planners’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$404K Buy
418
+102
+32% +$103K 0.3% 111
2025
Q4
$341K Sell
316
-8
-2% -$7.65K 0.27% 122
2025
Q3
$274K Buy
324
+60
+23% +$44.6K 0.23% 155
2025
Q2
$205K Sell
264
-13
-5% -$10.1K 0.19% 186
2025
Q1
$203K Sell
277
-25
-8% -$20.8K 0.21% 168
2024
Q4
$242K Buy
302
+32
+12% +$26.5K 0.24% 148
2024
Q3
$247K Sell
270
-1
-0.4% -$899 0.24% 155
2024
Q2
$255K Buy
271
+3
+1% +$2.4K 0.27% 141
2024
Q1
$200K Sell
268
-187
-41% -$133K 0.23% 171
2023
Q4
$284K Sell
455
-106
-19% -$61.9K 0.34% 106
2023
Q3
$331K Sell
561
-200
-26% -$103K 0.45% 86
2023
Q2
$357K Sell
761
-57
-7% -$23.9K 0.47% 83
2023
Q1
$332K Sell
818
-11
-1% -$3.71K 0.44% 87
2022
Q4
$290K Buy
+829
New +$294K 0.51% 72

Other funds holding LLY

Phillips Wealth Planners's LLY Position: Q1 2026 in Review

Phillips Wealth Planners increased its Eli Lilly (LLY) stake by 32% in Q1 2026, buying an estimated $103K and bringing the position to 418 shares worth $404K. The position accounts for 0.3% of the portfolio, ranked #111.

Phillips Wealth Planners first reported a position in LLY in Q4 2022 and has held it in 14 quarters since. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Phillips Wealth Planners held 418 shares of Eli Lilly worth $404K as of Q1 2026.
  • Phillips Wealth Planners bought 102 Eli Lilly shares in Q1 2026, an estimated $103K.
  • Eli Lilly made up 0.3% of Phillips Wealth Planners's portfolio in Q1 2026, its #111 holding.
  • Phillips Wealth Planners first reported a position in Eli Lilly in Q4 2022 and has held it in 14 quarters since.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Phillips Wealth Planners's 13F filing for Q1 2026, filed 14 May 2026.